Adgyl
Bengaluru, India adgyllifesciences.com From their website, Nov 2026
- GLP
- ISO 17025
- AAALAC
Work here? Claim this listing
About
Adgyl Lifesciences is a contract research organisation in Bangalore, India, providing preclinical and early clinical development support for pharmaceuticals, biologics, agrochemicals, cosmetics, medical devices, nutraceuticals, and industrial chemicals. It offers integrated discovery, non-clinical safety assessment, bioanalysis, and regulatory support for global submissions.
Services
Discovery Chemistry
Supports early target evaluation through hit identification, lead optimisation, synthetic chemistry, and analytical services for discovery programs.
In Vitro & In Vivo Pharmacology & In Vivo Imaging Solutions
Provides in vitro and in vivo efficacy studies, human-relevant models, translational research, and in vivo imaging for drug discovery and proof-of-concept work.
Assays & in vitro testing
DMPK
Offers in vitro ADMET and in vivo PK studies, including permeability, metabolism, metabolite profiling, bioavailability, tissue distribution, and toxicokinetic analysis.
In Vitro Toxicology
Performs human-relevant safety assays for irritation, sensitisation, endocrine disruption, phototoxicity, dermal absorption, and related endpoints using OECD-aligned methods.
Assays & in vitro testing
Exploratory Studies
Runs exploratory in vivo safety and exposure studies, including dose range finding, short repeat-dose studies, mini Ames, mini hERG, and telemetered dog cardiovascular assessments.
Genetic Toxicology
Provides genotoxicity testing such as Ames test, chromosomal aberration, and micronucleus assays for regulatory programs.
Assays & in vitro testing
Safety Pharmacology/De-risking
Supports cardiovascular, pulmonary, and CNS safety pharmacology studies to de-risk development programs.
Development & Reproductive Toxicology (DART)
Offers developmental and reproductive toxicology studies for non-clinical safety assessment.
6 more services
- Immunotoxicology
- Bioanalytical Services
- IND-Enabling Studies
- NDA Filing
- Biologics Inhalation Toxicity Studies
- Process Chemistry
- Turnaround
- On average 5 days for discovery-stage studies
- What to send
- In vitro and in vivo study samples for ADMET, PK, bioanalysis, and toxicology programs
Capabilities
- Assays and studies
- Toxicology
- In vivo
- Bioanalysis
- Rodent models
- PK/PD
- Analytical development
16 more
- BLI
- ADMET
- PK
- Radiolabelled DMPK
- Skin irritation
- Skin sensitisation
- Eye irritation
- Endocrine disruption
- Phototoxicity
- Dermal absorption
- Mini Ames
- Mini hERG
- Ames test
- Chromosomal aberration test
- Micronucleus test
- Functional observation battery
- Scale and capacity
- Over 200 rodent efficacy models
- Over 300 IND/NDA studies
- Over 30,000 regulatory studies
- More than 1,100 clients
- Therapeutic areas
- Oncology
- Immuno-oncology
- Metabolic disorders
- Cardiovascular disease
- CNS disorders
- Fibrosis
7 more
- Kidney disorders
- Wound healing
- Gastrointestinal disease
- Pain
- Inflammation
- Autoimmune diseases
- Ocular pharmacology
Instruments and platforms
- Phoenix WinNonlin 8.0
- Bioluminescence Imaging (BLI)
- Fluorescence Imaging (FLI)
- 3D Optical tomography
Modalities and species
- Modalities
- Small molecule
- Species and models
- Rodents
- Non-rodents
- Dogs
- Telemetered dogs
- Humanized mouse models
- Caco-2 cells
6 more
- MDCK cells
- H295R cells
- Balb/c 3T3 cells
- Reconstructed human epidermis
- Reconstructed human cornea-like epithelium
- Human peripheral blood lymphocytes
Details
- Type
- CRO
- Founded
- 2001
- Office
- Spring 2026 23- 26 March 2026, Lisbon, Portugal Booth: WRIB, 2026 14-16
- Sites
- Bangalore, India
- Serves
- Global